newratings.com  May 9  Comment 
NORTH CHICAGO (dpa-AFX) - Abbott's (ABT) pivotal clinical trial of Tecnis Symfony 1-Piece Acrylic Intraocular Lens has met its primary endpoint of improved intermediate vision. According to the trial results, people who received the Tecnis...
SeekingAlpha  May 6  Comment 
Red Orbit  Mar 25  Comment 
In trying to engineer the most basic form of life, genomics entrepreneur Craig Venter has synthesized a living cell using the least-ever amount of genes: 473. Documented in a report published by the journal Science, the genetic feat is the result...
Forbes  Mar 14  Comment 
“I take pride in teaching my students and trainees to start companies too, because it’s the only way I can scale." - Atul Butte, UCSF
Benzinga  Feb 9  Comment 
On Tuesday, Cowen and Company issued a company note on La Jolla Pharmaceutical Company (NASDAQ: LJPC) ahead of multiple drug trials for the company's pipeline. Currently, analysts at Cowen rate La Jolla Pharmaceutical as an Outperform with a $40...
Forbes  Jan 30  Comment 
Two ancient skeletons found in La Jolla, California, the subject of a decade-long legal battle, will be returned to Native Americans for repatriation.
New York Times  Jan 29  Comment 
For years the remains have been out of reach, the subject of a legal struggle that pitted 3 scientists against their own administration and the Kumeyaay.
GenEng News  Dec 10  Comment 
Scientists at the La Jolla Institute for Allergy and Immunology say they have demonstrated that TET (ten-eleven translocation) proteins collectively constitute a major class of tumor suppressors and are required to maintain genome stability. Their...
Benzinga  Nov 30  Comment 
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced the...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki